Mesa Laboratories Stock Price, News & Analysis (NASDAQ:MLAB)

$138.70 -0.26 (-0.19 %)
(As of 02/25/2018 08:56 AM ET)
Previous Close$138.70
Today's Range$135.45 - $140.73
52-Week Range$117.58 - $169.80
Volume3,352 shs
Average Volume21,224 shs
Market Capitalization$524.73 million
P/E Ratio59.02
Dividend Yield0.46%
Beta0.52

About Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories logoMesa Laboratories, Inc. is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products. Its Biological Indicators Division provides testing services, along with the manufacturing and marketing of biological indicators and distribution of chemical indicators used to assess the effectiveness of sterilization processes. Its Continuous Monitoring Division designs, develops and markets systems, which are used to monitor various environmental parameters. Its Cold Chain Division provides parameter (primarily temperature) monitoring of products in a cold chain. The Company's brands include DataTrace, DialyGuard, DryCal, Torqo, SureTorque, BGI, Mesa, PCD, Apex, CheckPoint, Mesa and TempTrust.

Receive MLAB News and Ratings via Email

Sign-up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Testing & Measuring Equipment
Sub-IndustryElectronic Equipment & Instruments
SectorMedical
SymbolNASDAQ:MLAB
CUSIP59064R10
Phone303-987-8000

Debt

Debt-to-Equity Ratio0.58%
Current Ratio2.37%
Quick Ratio1.64%

Price-To-Earnings

Trailing P/E Ratio59.02
Forward P/E Ratio-117.54
P/E GrowthN/A

Sales & Book Value

Annual Sales$93.67 million
Price / Sales5.60
Cash Flow$6.74 per share
Price / Cash20.57
Book Value$24.96 per share
Price / Book5.56

Profitability

Trailing EPS($1.00)
Net Income$11.18 million
Net Margins-3.82%
Return on Equity9.20%
Return on Assets5.37%

Miscellaneous

Employees381
Outstanding Shares3,780,000

Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories declared a quarterly dividend on Tuesday, January 2nd. Shareholders of record on Wednesday, February 28th will be paid a dividend of $0.16 per share on Thursday, March 15th. This represents a $0.64 dividend on an annualized basis and a yield of 0.46%. The ex-dividend date of this dividend is Tuesday, February 27th. View Mesa Laboratories' Dividend History.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) issued its earnings results on Monday, November, 6th. The medical instruments supplier reported $0.60 earnings per share for the quarter, missing the consensus estimate of $0.64 by $0.04. The medical instruments supplier had revenue of $22.95 million for the quarter, compared to the consensus estimate of $25.50 million. Mesa Laboratories had a negative net margin of 3.82% and a positive return on equity of 9.20%. View Mesa Laboratories' Earnings History.

Who are some of Mesa Laboratories' key competitors?

Who are Mesa Laboratories' key executives?

Mesa Laboratories' management team includes the folowing people:

  • John J. Sullivan Ph.D., Chairman of the Board (Age 73)
  • Gary M. Owens, President, Chief Executive Officer, Chief Operating Officer, Director (Age 49)
  • John V. Sakys, Chief Financial Officer, Executive Vice President, Chief Accounting Officer, Corporate Secretary (Age 49)
  • Glenn E. Adriance, Chief Sales and Marketing Officer (Age 61)
  • H. Stuart Campbell, Lead Independent Director (Age 86)
  • Robert V. Dwyer, Director (Age 75)
  • John Bradley Schmieder, Director (Age 47)
  • Michael T. Brooks, Independent Director (Age 66)
  • Evan C. Guillemin, Independent Director (Age 50)

Who owns Mesa Laboratories stock?

Mesa Laboratories' stock is owned by many different of retail and institutional investors. Top institutional shareholders include CONESTOGA CAPITAL ADVISORS, LLC (11.21%), Conestoga Capital Advisors LLC (11.21%), BlackRock Inc. (4.65%), Victory Capital Management Inc. (4.57%), Nine Ten Capital Management LLC (2.44%) and Thomson Horstmann & Bryant Inc. (2.34%). Company insiders that own Mesa Laboratories stock include David M Kelly, Glenn E Adriance, H Stuart Campbell, John Bradley Schmieder, John James Sullivan, John Sakys, Michael T Brooks and Robert V Dwyer. View Institutional Ownership Trends for Mesa Laboratories.

Who sold Mesa Laboratories stock? Who is selling Mesa Laboratories stock?

Mesa Laboratories' stock was sold by a variety of institutional investors in the last quarter, including Nine Ten Capital Management LLC, Renaissance Technologies LLC, Wasatch Advisors Inc., Pembroke Management LTD, Pennsylvania Trust Co, Metropolitan Life Insurance Co. NY, Rhumbline Advisers and Rice Hall James & Associates LLC. Company insiders that have sold Mesa Laboratories company stock in the last year include David M Kelly, Glenn E Adriance, H Stuart Campbell, John Bradley Schmieder, John James Sullivan, Michael T Brooks and Robert V Dwyer. View Insider Buying and Selling for Mesa Laboratories.

Who bought Mesa Laboratories stock? Who is buying Mesa Laboratories stock?

Mesa Laboratories' stock was purchased by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, Victory Capital Management Inc., King Luther Capital Management Corp, Thomson Horstmann & Bryant Inc., The Manufacturers Life Insurance Company , Deutsche Bank AG, ArrowMark Colorado Holdings LLC and Sapphire Star Partners LP. View Insider Buying and Selling for Mesa Laboratories.

How do I buy Mesa Laboratories stock?

Shares of Mesa Laboratories can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Mesa Laboratories' stock price today?

One share of Mesa Laboratories stock can currently be purchased for approximately $138.70.

How big of a company is Mesa Laboratories?

Mesa Laboratories has a market capitalization of $524.73 million and generates $93.67 million in revenue each year. The medical instruments supplier earns $11.18 million in net income (profit) each year or ($1.00) on an earnings per share basis. Mesa Laboratories employs 381 workers across the globe.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at 303-987-8000 or via email at [email protected]


MarketBeat Community Rating for Mesa Laboratories (MLAB)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  96 (Vote Outperform)
Underperform Votes:  90 (Vote Underperform)
Total Votes:  186
MarketBeat's community ratings are surveys of what our community members think about Mesa Laboratories and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Mesa Laboratories (NASDAQ:MLAB) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/ABuyBuy
Consensus Rating Score: N/AN/A3.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Mesa Laboratories (NASDAQ:MLAB) Consensus Price Target History

Price Target History for Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories (NASDAQ:MLAB) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/23/2016Janney Montgomery ScottReiterated RatingBuyN/AView Rating Details
6/10/2016SidotiDowngradeBuy -> Neutral$132.00N/AView Rating Details
(Data available from 2/25/2016 forward)

Earnings

Mesa Laboratories (NASDAQ:MLAB) Earnings History and Estimates Chart

Earnings by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories (NASDAQ MLAB) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/6/2017Q2 2018$0.64$0.60$25.50 million$22.95 millionViewN/AView Earnings Details
7/31/2017Q1 2018$0.56$0.39$22.90 million$22.67 millionViewN/AView Earnings Details
6/7/2017Q4 2017$1.00$1.24$27.10 million$24.30 millionViewN/AView Earnings Details
2/2/2017Q3 2017$0.62$1.19$22.60 million$23.84 millionViewN/AView Earnings Details
11/2/2016Q217$0.85$0.92$23.80 million$24.40 millionViewN/AView Earnings Details
7/28/2016Q1$0.89$0.89$21.20 million$21.11 millionViewN/AView Earnings Details
6/2/2016Q4$0.94$1.33$21.00 million$24.81 millionViewN/AView Earnings Details
2/2/2016Q3 2016$0.92$19.91 millionViewN/AView Earnings Details
11/2/2015Q2 2016$0.72$21.78 millionViewN/AView Earnings Details
8/3/2015Q116$0.83$0.85$18.78 billion$18.20 billionViewN/AView Earnings Details
6/1/2015Q415$0.91$0.80$18.56 millionViewN/AView Earnings Details
2/2/2015Q315$0.73$0.87$17.83 millionViewN/AView Earnings Details
11/3/2014Q215$0.69$0.84$12.68 million$18.54 millionViewN/AView Earnings Details
8/6/2014Q115$0.67$0.71$11.22 million$16.40 millionViewN/AView Earnings Details
6/2/2014Q414$0.70$1.15$12.80 million$15.70 millionViewN/AView Earnings Details
2/3/2014Q4$0.62$13.12 millionViewN/AView Earnings Details
11/5/2013Q2 2014$0.65$12.68 millionViewN/AView Earnings Details
8/6/2013Q1 2014$0.63$11.22 millionViewN/AView Earnings Details
5/29/2013Q113$0.59$0.76$13.13 million$12.81 millionViewN/AView Earnings Details
2/5/2013Q3 2013$0.67$0.56$11.76 million$11.36 millionViewN/AView Earnings Details
11/8/2012Q312$0.61$0.76$11.48 million$11.71 millionViewN/AView Earnings Details
8/9/2012Q1 2013$0.70ViewN/AView Earnings Details
5/23/2012Q4 2012$0.76ViewN/AView Earnings Details
2/8/2012Q3 2012$0.63ViewN/AView Earnings Details
11/9/2011Q2 2012$0.66ViewN/AView Earnings Details
8/10/2011Q1 2012$0.56ViewN/AView Earnings Details
6/8/2011Q4 2011$0.71ViewN/AView Earnings Details
2/14/2011Q3 2011$0.43ViewN/AView Earnings Details
11/10/2010Q2 2011$0.48ViewN/AView Earnings Details
8/16/2010Q1 2011$0.44ViewN/AView Earnings Details
5/25/2010Q4 2010$0.40ViewN/AView Earnings Details
2/11/2010Q3 2010$0.35ViewN/AView Earnings Details
11/12/2009Q2 2010$0.38ViewN/AView Earnings Details
8/11/2009Q1 2010$0.31ViewN/AView Earnings Details
5/26/2009Q4 2009$0.37ViewN/AView Earnings Details
2/10/2009Q3 2009$0.38ViewN/AView Earnings Details
11/10/2008Q2 2009$0.42ViewN/AView Earnings Details
8/12/2008Q1 2009$0.31ViewN/AView Earnings Details
5/19/2008Q4 2008$0.36ViewN/AView Earnings Details
2/11/2008Q3 2008$0.34ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Mesa Laboratories (NASDAQ:MLAB) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.18 EPS
Next Year EPS Consensus Estimate: $3.13 EPS

Dividends

Mesa Laboratories (NASDAQ:MLAB) Dividend Information

Next Dividend:3/15/2018
Annual Dividend:$0.64
Dividend Yield:0.46%
Dividend Growth:1.60% (3 Year Average)
Payout Ratio:-64.00% (Trailing 12 Months of Earnings)
-54.24% (Based on This Year's Estimates)
20.45% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories (NASDAQ:MLAB) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/2/2018Quarterly$0.160.51%2/27/20182/28/20183/15/2018
10/3/2017quarterly$0.160.42%11/29/201711/30/201712/15/2017
7/6/2017quarterly$0.160.45%8/29/20178/31/20179/15/2017
4/6/2017quarterly$0.160.5%5/26/20175/31/20176/15/2017
1/4/2017quarterly$0.160.51%2/24/20172/28/20173/15/2017
10/5/2016quarterly$0.160.54%11/28/201611/30/201612/15/2016
7/7/2016quarterly$0.160.52%8/29/20168/31/20169/15/2016
4/13/2016quarterly$0.160.64%5/26/20165/31/20166/15/2016
1/6/2016quarterly$0.160.71%2/25/20162/29/20163/15/2016
10/5/2015quarterly$0.160.57%11/25/201511/30/201512/15/2015
7/9/2015quarterly$0.160.72%8/27/20158/31/20159/15/2015
4/3/2015quarterly$0.160.93%5/27/20155/29/20156/15/2015
1/7/2015quarterly$0.160.84%2/25/20152/27/20153/16/2015
10/14/2014quarterly$0.160.95%11/25/201411/28/201412/15/2014
7/17/2014quarterly$0.150.73%8/27/20148/29/20149/15/2014
4/23/2014quarterly$0.150.69%5/28/20145/30/20146/16/2014
1/31/2014quarterly$0.150.75%2/26/20142/28/20143/17/2014
11/1/2013quarterly$0.150.88%11/26/201311/29/201312/16/2013
8/7/2013quarterly$0.140.92%8/28/20138/30/20139/18/2013
4/18/2013quarterly$0.141.1%5/22/20135/27/20136/24/2013
4/17/2013quarterly$0.145/27/20136/14/2013
2/6/2013quarterly$0.141.08%2/25/20132/27/20133/15/2013
(Data available from 1/1/2013 forward)

Insider Trades

Mesa Laboratories (NASDAQ MLAB) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 15.70%
Institutional Ownership Percentage: 72.77%
Insider Trades by Quarter for Mesa Laboratories (NASDAQ:MLAB)
Institutional Ownership by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories (NASDAQ MLAB) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/16/2018John James SullivanDirectorSell4,000$138.00$552,000.0072,248View SEC Filing  
2/8/2018John Bradley SchmiederDirectorSell3,000$132.27$396,810.0077,869View SEC Filing  
8/21/2017H Stuart CampbellDirectorSell1,000$130.16$130,160.0042,366View SEC Filing  
8/18/2017H Stuart CampbellDirectorSell2,000$130.42$260,840.0044,366View SEC Filing  
8/15/2017H Stuart CampbellDirectorSell2$134.10$268.2045,366View SEC Filing  
8/11/2017H Stuart CampbellDirectorSell608$134.08$81,520.6445,368View SEC Filing  
8/10/2017H Stuart CampbellDirectorSell1,000$136.58$136,580.0045,976View SEC Filing  
8/9/2017H Stuart CampbellDirectorSell1,000$137.61$137,610.0046,976View SEC Filing  
8/4/2017H Stuart CampbellDirectorSell1,000$143.09$143,090.0047,976View SEC Filing  
8/3/2017H Stuart CampbellDirectorSell2,000$143.37$286,740.0049,976View SEC Filing  
6/16/2017Robert V DwyerDirectorSell11,150$139.46$1,554,979.0080,671View SEC Filing  
6/12/2017David M KellyDirectorSell1,000$142.00$142,000.004,750View SEC Filing  
6/9/2017Glenn E AdrianceInsiderSell4,000$148.98$595,920.0010,000View SEC Filing  
3/20/2017Michael T BrooksDirectorSell2,000$122.94$245,880.0028,900View SEC Filing  
2/22/2017Robert V DwyerDirectorSell5,000$125.13$625,650.0087,971View SEC Filing  
2/21/2017John James SullivanInsiderSell9,078$124.83$1,133,206.7464,278View SEC Filing  
2/13/2017John James SullivanCEOSell5,922$123.99$734,268.7868,040View SEC Filing  
2/7/2017Glenn E AdrianceInsiderSell8,070$124.15$1,001,890.5015,170View SEC Filing  
2/7/2017H Stuart CampbellDirectorSell8,000$121.55$972,400.0055,930View SEC Filing  
11/23/2016Glenn E AdrianceInsiderSell3,567$135.93$484,862.3115,525View SEC Filing  
11/17/2016John SakysCFOSell1,000$127.14$127,140.002,000View SEC Filing  
10/21/2016H Stuart CampbellDirectorSell4,000$119.02$476,080.0063,930View SEC Filing  
9/16/2016H Stuart CampbellDirectorSell3,000$115.03$345,090.0067,930View SEC Filing  
6/22/2016John James SullivanCEOSell4,000$121.63$486,520.0066,118View SEC Filing  
6/6/2016Glenn E AdrianceInsiderSell3,000$111.74$335,220.0014,100View SEC Filing  
3/11/2016H Stuart CampbellDirectorSell6,000$86.32$517,920.0073,887View SEC Filing  
3/7/2016H Stuart CampbellDirectorSell280$90.00$25,200.0076,071View SEC Filing  
2/24/2016H Stuart CampbellDirectorSell1,532$92.90$142,322.8079,766View SEC Filing  
11/6/2015John James SullivanCEOSell2,400$112.99$271,176.0061,393View SEC Filing  
9/22/2015H Stuart CampbellDirectorBuy150$109.54$16,431.0078,848View SEC Filing  
9/17/2015Robert V DwyerDirectorSell2,000$113.00$226,000.0092,373View SEC Filing  
9/15/2015Robert V DwyerDirectorSell3,000$111.67$335,010.0094,373View SEC Filing  
9/11/2015Robert V DwyerDirectorSell1,000$110.00$110,000.0097,373View SEC Filing  
9/8/2015Robert V DwyerDirectorSell1,000$110.39$110,390.0098,373View SEC Filing  
8/17/2015Robert V DwyerDirectorSell1,937$116.50$225,660.50View SEC Filing  
3/14/2014Luke R SchmiederDirectorSell5,000$90.04$450,200.00View SEC Filing  
2/27/2014Glenn E AdrianceInsiderSell1,000$87.68$87,680.00View SEC Filing  
2/25/2014John James SullivanCEOSell10,000$87.01$870,100.00View SEC Filing  
12/9/2013Glenn E AdrianceInsiderSell4,825$73.68$355,506.00View SEC Filing  
11/15/2013Robert V DwyerDirectorSell13,476$71.33$961,243.08View SEC Filing  
11/14/2013Robert V DwyerDirectorSell6,524$71.33$465,356.92View SEC Filing  
8/19/2013John James SullivanCEOSell6,000$64.87$389,220.00View SEC Filing  
8/14/2013John James SullivanCEOSell6,000$61.92$371,520.00View SEC Filing  
3/5/2013H Stuart CampbellDirectorSell30,000$52.75$1,582,500.00View SEC Filing  
12/27/2012Steven W PetersonCFOSell17,054$48.50$827,119.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Mesa Laboratories (NASDAQ MLAB) News Headlines

Source:
DateHeadline
Investors In Mesa Laboratories Inc (NASDAQ:MLAB) Are Paying Above The Intrinsic ValueInvestors In Mesa Laboratories Inc (NASDAQ:MLAB) Are Paying Above The Intrinsic Value
finance.yahoo.com - February 23 at 5:34 PM
John James Sullivan Sells 4,000 Shares of Mesa Laboratories, Inc. (MLAB) StockJohn James Sullivan Sells 4,000 Shares of Mesa Laboratories, Inc. (MLAB) Stock
www.americanbankingnews.com - February 20 at 12:16 PM
 Mesa Laboratories, Inc. (MLAB) Given Average Rating of "Strong Buy" by Analysts Mesa Laboratories, Inc. (MLAB) Given Average Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - February 15 at 1:28 AM
Mesa Laboratories (MLAB) Lowered to "C" at TheStreetMesa Laboratories (MLAB) Lowered to "C" at TheStreet
www.americanbankingnews.com - February 10 at 1:56 PM
Mesa Laboratories (MLAB) Downgraded by Zacks Investment Research to SellMesa Laboratories (MLAB) Downgraded by Zacks Investment Research to Sell
www.americanbankingnews.com - February 10 at 6:28 AM
Insider Selling: Mesa Laboratories, Inc. (MLAB) Director Sells 3,000 Shares of StockInsider Selling: Mesa Laboratories, Inc. (MLAB) Director Sells 3,000 Shares of Stock
www.americanbankingnews.com - February 8 at 6:16 PM
CBMG Up 50% YTD, HAIR Keeps Falling, MNOV To Report NASH Trial Data In AprilCBMG Up 50% YTD, HAIR Keeps Falling, MNOV To Report NASH Trial Data In April
www.nasdaq.com - February 8 at 8:27 AM
Mesa Labs reports 3Q lossMesa Labs reports 3Q loss
finance.yahoo.com - February 6 at 9:36 AM
Are Mesa Laboratories Inc’s (NASDAQ:MLAB) Interest Costs Too High?Are Mesa Laboratories Inc’s (NASDAQ:MLAB) Interest Costs Too High?
finance.yahoo.com - January 31 at 10:04 AM
Zacks: Mesa Laboratories, Inc. (MLAB) Receives Consensus Recommendation of "Strong Buy" from BrokeragesZacks: Mesa Laboratories, Inc. (MLAB) Receives Consensus Recommendation of "Strong Buy" from Brokerages
www.americanbankingnews.com - January 31 at 5:16 AM
Mesa Laboratories (MLAB) Set to Announce Quarterly Earnings on WednesdayMesa Laboratories (MLAB) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - January 24 at 3:56 AM
 Mesa Laboratories, Inc. (MLAB) Given Average Recommendation of "Strong Buy" by Analysts Mesa Laboratories, Inc. (MLAB) Given Average Recommendation of "Strong Buy" by Analysts
www.americanbankingnews.com - January 16 at 9:56 AM
Rudolph Technologies (RTEC) versus Mesa Laboratories (MLAB) Head to Head ContrastRudolph Technologies (RTEC) versus Mesa Laboratories (MLAB) Head to Head Contrast
www.americanbankingnews.com - January 11 at 3:34 PM
Mesa Laboratories, Inc. to Issue Quarterly Dividend of $0.16 (MLAB)Mesa Laboratories, Inc. to Issue Quarterly Dividend of $0.16 (MLAB)
www.americanbankingnews.com - January 3 at 12:36 PM
Mesa Labs Declares Quarterly DividendMesa Labs Declares Quarterly Dividend
finance.yahoo.com - January 2 at 6:58 PM
Zacks: Analysts Set $175.00 Price Target for Mesa Laboratories, Inc. (MLAB)Zacks: Analysts Set $175.00 Price Target for Mesa Laboratories, Inc. (MLAB)
www.americanbankingnews.com - January 1 at 1:56 AM
Head-To-Head Survey: MKS Instruments (MKSI) vs. Mesa Laboratories (MLAB)Head-To-Head Survey: MKS Instruments (MKSI) vs. Mesa Laboratories (MLAB)
www.americanbankingnews.com - December 28 at 3:21 AM
Head to Head Survey: Mesa Laboratories (MLAB) versus MKS Instruments (MKSI)Head to Head Survey: Mesa Laboratories (MLAB) versus MKS Instruments (MKSI)
www.americanbankingnews.com - December 28 at 3:21 AM
Brokerages Expect Mesa Laboratories, Inc. (MLAB) to Announce $0.61 Earnings Per ShareBrokerages Expect Mesa Laboratories, Inc. (MLAB) to Announce $0.61 Earnings Per Share
www.americanbankingnews.com - December 16 at 7:26 PM
MKS Instruments (MKSI) and Mesa Laboratories (MLAB) Critical ContrastMKS Instruments (MKSI) and Mesa Laboratories (MLAB) Critical Contrast
www.americanbankingnews.com - December 12 at 9:34 PM
Analysts Expect Mesa Laboratories, Inc. (MLAB) to Post $0.61 EPSAnalysts Expect Mesa Laboratories, Inc. (MLAB) to Post $0.61 EPS
www.americanbankingnews.com - December 8 at 11:52 PM
Mesa Laboratories, Inc. : MLAB-US: Dividend Analysis : November 30th, 2017 (record date) : By the numbers : November 30, 2017Mesa Laboratories, Inc. : MLAB-US: Dividend Analysis : November 30th, 2017 (record date) : By the numbers : November 30, 2017
finance.yahoo.com - November 30 at 5:30 PM
 Mesa Laboratories, Inc. (MLAB) Given $175.00 Average Price Target by Brokerages Mesa Laboratories, Inc. (MLAB) Given $175.00 Average Price Target by Brokerages
www.americanbankingnews.com - November 23 at 1:52 AM
 Mesa Laboratories, Inc. (MLAB) Given Consensus Rating of "Strong Buy" by Analysts Mesa Laboratories, Inc. (MLAB) Given Consensus Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - November 19 at 9:26 PM
Mesa Labs Acquires Sterilization and Disinfection Process Control BusinessMesa Labs Acquires Sterilization and Disinfection Process Control Business
finance.yahoo.com - November 9 at 5:37 AM
Mesa Laboratories, Inc. (MLAB) Releases Quarterly  Earnings Results, Misses Estimates By $0.04 EPSMesa Laboratories, Inc. (MLAB) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS
www.americanbankingnews.com - November 7 at 12:34 PM
Colorado instrument company reports its reducing headcountColorado instrument company reports it's 'reducing headcount'
www.bizjournals.com - November 7 at 6:55 AM
Mesa Labs Reports Second Quarter ResultsMesa Labs Reports Second Quarter Results
www.thestreet.com - November 7 at 6:55 AM
Mid-Day Market Update: Mesa Laboratories Drops After Q2 Results; TherapeuticsMD Shares JumpMid-Day Market Update: Mesa Laboratories Drops After Q2 Results; TherapeuticsMD Shares Jump
feeds.benzinga.com - November 6 at 12:54 PM
Zacks: Mesa Laboratories, Inc. (MLAB) Given Average Rating of "Strong Buy" by AnalystsZacks: Mesa Laboratories, Inc. (MLAB) Given Average Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - November 4 at 7:40 PM
ETFs with exposure to Mesa Laboratories, Inc. : November 1, 2017ETFs with exposure to Mesa Laboratories, Inc. : November 1, 2017
finance.yahoo.com - November 2 at 6:28 AM
 Analysts Set $190.00 Price Target for Mesa Laboratories, Inc. (MLAB) Analysts Set $190.00 Price Target for Mesa Laboratories, Inc. (MLAB)
www.americanbankingnews.com - October 28 at 7:50 PM
Mesa Laboratories (MLAB) and Vishay Precision Group (VPG) Head to Head AnalysisMesa Laboratories (MLAB) and Vishay Precision Group (VPG) Head to Head Analysis
www.americanbankingnews.com - October 19 at 4:10 PM
Zacks: Analysts Set $190.00 Target Price for Mesa Laboratories, Inc. (MLAB)Zacks: Analysts Set $190.00 Target Price for Mesa Laboratories, Inc. (MLAB)
www.americanbankingnews.com - October 18 at 6:40 PM
Comparing Mesa Laboratories (MLAB) & BTU International (BTUI)Comparing Mesa Laboratories (MLAB) & BTU International (BTUI)
www.americanbankingnews.com - October 16 at 12:32 PM
Comparing Mesa Laboratories (MLAB) and The CompetitionComparing Mesa Laboratories (MLAB) and The Competition
www.americanbankingnews.com - October 14 at 8:22 PM
Head to Head Survey: Mesa Laboratories (MLAB) vs. Its CompetitorsHead to Head Survey: Mesa Laboratories (MLAB) vs. Its Competitors
www.americanbankingnews.com - October 14 at 2:18 AM
BRIEF-Mlabs Systems says entered into collaboration agreement with Malaysian University Of Science and TechnologyBRIEF-Mlabs Systems says entered into collaboration agreement with Malaysian University Of Science and Technology
finance.yahoo.com - October 13 at 6:54 AM
Brokerages Anticipate Mesa Laboratories, Inc. (MLAB) to Announce $0.55 EPSBrokerages Anticipate Mesa Laboratories, Inc. (MLAB) to Announce $0.55 EPS
www.americanbankingnews.com - October 11 at 2:20 PM
Analysts Expect Mesa Laboratories, Inc. (MLAB) to Announce $0.55 Earnings Per ShareAnalysts Expect Mesa Laboratories, Inc. (MLAB) to Announce $0.55 Earnings Per Share
www.americanbankingnews.com - October 7 at 12:36 PM
ETFs with exposure to Mesa Laboratories, Inc. : October 5, 2017ETFs with exposure to Mesa Laboratories, Inc. : October 5, 2017
finance.yahoo.com - October 7 at 6:03 AM
The Zacks Analyst Blog Highlights: PRA Health Sciences, Mesa Laboratories, ConforMIS, Check-Cap and Streamline Health SolutionsThe Zacks Analyst Blog Highlights: PRA Health Sciences, Mesa Laboratories, ConforMIS, Check-Cap and Streamline Health Solutions
finance.yahoo.com - October 6 at 10:38 AM
Mesa Laboratories (MLAB) vs. The Competition Financial ReviewMesa Laboratories (MLAB) vs. The Competition Financial Review
www.americanbankingnews.com - October 5 at 10:20 PM
Mesa Labs Acquires Sterilization Process Control BusinessMesa Labs Acquires Sterilization Process Control Business
feeds.benzinga.com - October 5 at 4:22 PM
Mesa Laboratories, Inc. (MLAB) to Issue Quarterly Dividend of $0.16Mesa Laboratories, Inc. (MLAB) to Issue Quarterly Dividend of $0.16
www.americanbankingnews.com - October 3 at 6:04 PM
Head-To-Head Review: BTU International (BTUI) versus Mesa Laboratories (MLAB)Head-To-Head Review: BTU International (BTUI) versus Mesa Laboratories (MLAB)
www.americanbankingnews.com - October 3 at 12:50 PM
Contrasting Mesa Laboratories (MLAB) & Its RivalsContrasting Mesa Laboratories (MLAB) & Its Rivals
www.americanbankingnews.com - September 30 at 6:26 AM
Mesa Laboratories (MLAB) and Its Competitors Critical ReviewMesa Laboratories (MLAB) and Its Competitors Critical Review
www.americanbankingnews.com - September 25 at 2:18 PM
Mesa Laboratories, Inc. : MLAB-US: Dividend Analysis : August 31st, 2017 (record date) : By the numbers : September 22, 2017Mesa Laboratories, Inc. : MLAB-US: Dividend Analysis : August 31st, 2017 (record date) : By the numbers : September 22, 2017
finance.yahoo.com - September 23 at 8:14 AM
Analyzing Chart Industries (GTLS) and Mesa Laboratories (MLAB)Analyzing Chart Industries (GTLS) and Mesa Laboratories (MLAB)
www.americanbankingnews.com - September 22 at 2:34 PM

SEC Filings

Mesa Laboratories (NASDAQ:MLAB) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Mesa Laboratories (NASDAQ:MLAB) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Mesa Laboratories (NASDAQ MLAB) Stock Chart for Sunday, February, 25, 2018

Loading chart…

This page was last updated on 2/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.